Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice

Sodium-glucose co-transporters (SGLTs) serve to reabsorb glucose in the kidney. Recently, these transporters, mainly SGLT2, have emerged as new therapeutic targets for patients with diabetes and kidney disease; by inhibiting glucose reabsorption, they promote glycosuria, weight loss, and improve glu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurtz, Ryan, Libby, Andrew, Jones, Bryce A., Myakala, Komuraiah, Wang, Xiaoxin, Lee, Yichien, Knoer, Grace, Lo Cascio, Julia N., McCormack, Michaela, Nguyen, Grace, Choos, Elijah N. D., Rodriguez, Olga, Rosenberg, Avi Z., Ranjit, Suman, Albanese, Christopher, Levi, Moshe, Ecelbarger, Carolyn M., Shepard, Blythe D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147974/
https://www.ncbi.nlm.nih.gov/pubmed/35628485
http://dx.doi.org/10.3390/ijms23105675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147974/
https://www.ncbi.nlm.nih.gov/pubmed/35628485
http://dx.doi.org/10.3390/ijms23105675

Ejemplares similares